Literature DB >> 18948243

Comparison of 3 different incisions used for atrial-septal defect closure.

Murat Basaran1, Ali Kocailik, Cihan Ozbek, Alper Ucak, Eylul Kafali, Melih Us.   

Abstract

BACKGROUND: Surgical closure of atrial-septal defects is now associated with low morbidity and mortality rates. We assessed surgical, cosmetic, and psychological results of 3 different surgical approaches to atrial-septal defect repair.
METHODS: Study participants were 82 patients who underwent surgery for atrial-septal defect. Mean age was 21 +/- 8 years, and the female:male ratio was 23:59. Patients were divided into 3 groups according to the incision used; group 1 (n = 26), partial lower sternotomy; group 2 (n = 34), right anterolateral thoracotomy via a submammary incision, and group 3 (n = 22), conventional median sternotomy.
RESULTS: There was no operative or late mortality. No significant differences between groups were associated with the surgical technique used. Direct closure was the procedure of choice performed in 53 patients (64.6%). In the remaining patients the repair was performed with a pericardial patch (29 patients, 35.4%). One patient in group 1 required conversion to median sternotomy because transoesophageal echocardiography performed at the operating theater revealed a partial anomalous pulmonary venous connection of right pulmonary veins to the inferior vena cava. This patient was excluded from the study group. All patients were symptom free postoperatively, and control echocardiography revealed a trivial shunt in only 1 patient, with a Qp:Qs ratio of 1.3. Rhythm abnormalities, including atrioventricular block, atrial fibrillation, and flutter, were observed in 7 patients but were found to be unrelated to the surgical incision (P = .3). Cardiopulmonary bypass, cross-clamp, and operative times were longer with minimally invasive approaches; but these differences were not statistically significant. Intensive care unit and hospital stay periods were significantly shorter in groups 1 and 2. During the postoperative follow-up period, patients in groups 1 and 2 showed superior results in satisfaction with their cosmetic outcomes.
CONCLUSIONS: With the development of minimally invasive techniques that yield surgical results comparable to those of standard techniques, surgeons have changed their focus from survival to cosmetic and psychological outcomes, especially in the repair of simple cardiac defects. Operations performed via limited skin incisions are surgically safe and provide superior cosmetic and psychological results.

Entities:  

Mesh:

Year:  2008        PMID: 18948243     DOI: 10.1532/HSF98.20081060

Source DB:  PubMed          Journal:  Heart Surg Forum        ISSN: 1098-3511            Impact factor:   0.676


  4 in total

Review 1.  Anterolateral minithoracotomy versus median sternotomy for the treatment of congenital heart defects: a meta-analysis and systematic review.

Authors:  Chao Ding; Chunmao Wang; Aiqiang Dong; Minjian Kong; Daming Jiang; Kaiyu Tao; Zhonghua Shen
Journal:  J Cardiothorac Surg       Date:  2012-05-04       Impact factor: 1.637

2.  Anterolateral minithoracotomy versus median sternotomy for the surgical treatment of atrial septal defects: a meta-analysis and systematic review.

Authors:  Yu-Qing Lei; Jian-Feng Liu; Wen-Peng Xie; Zhi-Nuan Hong; Qiang Chen; Hua Cao
Journal:  J Cardiothorac Surg       Date:  2021-09-20       Impact factor: 1.637

3.  Comparative Study between Surgical Repair of Atrial Septal Defect via Median Sternotomy, Right Submammary Thoracotomy, and Right Vertical Infra-Axillary Thoracotomy.

Authors:  Zeng-Rong Luo; Qiang Chen; Ling-Li Yu; Liang-Wan Chen; Zhong-Yao Huang
Journal:  Braz J Cardiovasc Surg       Date:  2020-06-01

4.  Open heart surgery or echocardiographic transthoracic or percutaneous closure in secundum atrial septal defect: a developing approach in one Chinese hospital.

Authors:  Hongwei Qi; Jiangang Zhao; Xiujie Tang; Xizheng Wang; Nan Chen; Wenqing Lv; Hong Bian; Shumin Wang; Biao Yuan
Journal:  J Cardiothorac Surg       Date:  2020-08-06       Impact factor: 1.637

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.